JAN 09, 2021 7:18 AM PST

Automated system provides guidance for cancer patients' symptoms

A new computer system called eRAPID has been debuted in a UK trial to test out how it can assist cancer patients in managing symptoms. The system, designed by the University of Leeds, was developed to offer guidance to cancer patients so as to ameliorate their wellbeing.

The online eHealth system was tested by early-stage colorectal, breast, and gynecological cancer patients who were able to update their symptoms into eRAPID and receive automated severity-dependent advice, which either suggests ways to manage the symptoms or recommends patients to seek medical assistance. Such an automated system is beneficial in that it can decrease clinicians’ workload by answering commonly asked questions without patients requiring direct contact with physicians.

The trial evaluated the impact of the eRAPID system by analyzing how it improved symptom control, healthcare use, patient self-efficacy, and quality of life (QOL). The results showed that patients reported better symptom control and physical wellbeing in the early weeks of treatment, with the system preventing symptom deterioration in about 9% of patients after 12 weeks. Overall, patients also reported more confidence in managing their health.

"Rising numbers of cancer patients are receiving a range of anti-cancer treatments which means patients are living longer and require longer periods of care and monitoring,” commented Program lead Professor Galina Velikova, at the Leeds Institute of Medical Research at St James's. "Remote online monitoring options have the potential to be a patient-centered, safe, and effective approach to support patients during cancer treatment and manage the growing clinical workload for cancer care."

Photo: Pexels

Dr. Kate Absolom adds that this trial is extremely needed considering the limitations that the pandemic have put on in-person healthcare: "The encouraging results from this study will help pave the way for future development and refinement of these interventions in broader cancer settings. The COVID19 pandemic highlighted the need and speeded a shift towards technology-enabled care, so these study results are very timely."

It can often be difficult for cancer patients to know what symptoms are normal and expected when undergoing treatment versus what symptoms are dangerous and require medical attention. The trial showed that the electronic system increased patient confidence in managing their mild and moderate treatment-related symptoms and did not compromise patient safety or treatment delivery.

Sources: Journal of Clinical Oncology, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
OCT 22, 2020
Cancer
Cancer cells don't like crowded spaces
OCT 22, 2020
Cancer cells don't like crowded spaces
Researchers collaborating from St. Anna Children's Cancer Research Institute Vienna, King's College London, Inst ...
NOV 06, 2020
Drug Discovery & Development
Anti-depressant Shows Promise in Treating Childhood Cancer
NOV 06, 2020
Anti-depressant Shows Promise in Treating Childhood Cancer
Researchers from Sweden and the US have found that a commonly prescribed antidepressant may help stop the growth of a ca ...
NOV 07, 2020
Cancer
Newly identified biomarker sheds light on antiangiogenic drug responses
NOV 07, 2020
Newly identified biomarker sheds light on antiangiogenic drug responses
A study published last week in the journal EMBO Molecular Medicine provides insight into the molecular mechanisms t ...
NOV 13, 2020
Cancer
Predictive model assesses risk of adverse side effects for chemotherapy patients
NOV 13, 2020
Predictive model assesses risk of adverse side effects for chemotherapy patients
New research published in npj Systems Biology and Applications showcases a model capable of predicting which patien ...
JAN 05, 2021
Cancer
Two gene expression subtypes identified in peritoneal carcinomatosis cells
JAN 05, 2021
Two gene expression subtypes identified in peritoneal carcinomatosis cells
New research published in Nature Medicine finds two subtypes of gene expression in peritoneal carcinomatosis (PC) that c ...
JAN 15, 2021
Genetics & Genomics
Rare Quadruple Helix DNA Found in Live Human Cells
JAN 15, 2021
Rare Quadruple Helix DNA Found in Live Human Cells
Many people picture the classic double-stranded helix when picturing a molecule of DNA, but DNA is also capable of formi ...
Loading Comments...